• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags FDA

    Tag: FDA

    Kratom capsules are displayed in Albany, N.Y. Federal health authorities  are warning about reports of injury, addiction and death with the herbal supplement that has been promoted as an alternative to opioid painkillers and other prescription drugs.
    Healthcare

    Kratom advocates fight FDA crackdown

    Robert King -
    June 5, 2018 4:01 am
    0
    President Donald Trump holds up the "Right to Try" act after signing it in the South Court Auditorium on the White House campus, Wednesday, May 30, 2018, in Washington.
    Beltway Confidential

    Trump keeps his promise, dying patients get a second chance at life

    Tim Huelskamp, Arianna Wilkerson -
    June 4, 2018 8:05 pm
    0
    Sen. Ron Johnson, R-Wis., talks during a hearing on Capitol Hill in Washington, D.C.
    Healthcare

    Ron Johnson warns FDA not to mess with law giving patients ‘right to try’ experimental drugs

    Robert King -
    May 31, 2018 9:44 pm
    0
    E-cigarette devices are shown above. They heat liquid into an inhalable vapor that's sold in sugary flavors like mango and mint, and often with the addictive drug nicotine.
    Beltway Confidential

    Despite JUUL crackdown, vaping is still (way) safer than smoking

    Nicolas John -
    May 31, 2018 6:06 pm
    0
    President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)
    Healthcare

    FDA tackles ‘gaming’ of brand-name drugs

    Kimberly Leonard -
    May 31, 2018 5:45 pm
    0
    Child repeatedly tries, eventually succeeds in hugging Trump at 'Right To Try' bill signing: Watch
    Healthcare

    Child repeatedly tries, eventually succeeds in hugging Trump at 'Right To Try' bill signing: Watch

    Naomi Lim -
    May 30, 2018 6:04 pm
    0
    President Trump signs something in the White House.
    Healthcare

    Trump signs bill giving terminally ill patients ‘right to try’ experimental drugs

    Robert King -
    May 30, 2018 4:50 pm
    0
    This scanning electron micrograph shows Salmonella typhimurium (red) invading human cells.
    Healthcare

    Government ends investigation of salmonella-contaminated kratom

    Kimberly Leonard -
    May 24, 2018 9:46 pm
    0
    Food and Drug Administration Commissioner Scott Gottlieb listens during an interview with The Associated Press in New York on Monday, March 5, 2018. Gottlieb said Monday that he needs more staffers to intercept opioids that are being disguised as other drugs and supplements.
    Healthcare

    FDA head worries drug companies will abandon making cheaper drugs

    Robert King -
    May 23, 2018 1:49 pm
    0
    Pills move through a precision weighing machine at the Interphex2006 pharmaceutical manufacturers trade show in New York.
    Healthcare

    House votes to give terminally ill patients the ‘right to try’ experimental drugs

    Robert King -
    May 22, 2018 9:26 pm
    0
    1...118119120...182Page 119 of 182
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.